Ionis pharmaceuticals stock price today
WebIonis Pharmaceuticals, Inc. (IONS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 37.23 +0.32 (+0.87%) At close: 04:00PM EDT 37.23 0.00 … WebIonis Pharmaceuticals (IONS) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 5,327,896 Shares Outstanding, K 142,954 Annual Sales, $ 587,370 K Annual Income, $ -269,720 K 60-Month Beta 0.54 Price/Sales 8.91 Price/Cash Flow N/A Price/Book 9.07
Ionis pharmaceuticals stock price today
Did you know?
WebIonis Pharmaceuticals stock price target cut to $76 from $90 at BMO Capital Mar. 23, 2024 at 8:51 a.m. ET by Tomi Kilgore Biotech and Pharma Ionis Stock Plunges as … WebWith Ionis Pharmaceuticals stock trading at $35.48 per share, the total value of Ionis Pharmaceuticals stock (market capitalization) is $5.07B. Ionis Pharmaceuticals stock …
WebIonis Pharmaceuticals, Inc. Common Stock (IONS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Web12 apr. 2024 · See the latest Ionis Pharmaceuticals Inc stock price (NASDAQ:IONS), related news, valuation, dividends and more to help you make your investing decisions.
Web11 apr. 2024 · In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Ionis Pharmaceuticals, with a price target of $42.00. The company’s … WebIonis Pharmaceuticals, Inc. (IONS): $37.27 0.68 (+1.86%) POWR Rating Component Grades Sign Up to See Ratings...FREE! We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now. Just click the link above. Growth S Value I Momentum G Stability N Sentiment U Quality P Add IONS to Watchlist
Web29 jun. 2024 · BOSTON, June 29, 2024 /PRNewswire/ -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Tracy Palmer Berns has joined the ...
Web11 apr. 2024 · In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Ionis Pharmaceuticals, with a price target of $42.00. The company’s shares closed last Tuesday at $37.00. fish in uestcWebIONS: Ionis Pharmaceuticals Inc - Stock Price, Quote and News - CNBC Ionis Pharmaceuticals Inc IONS:NASDAQ EXPORT WATCHLIST + RT Quote Last … can chickens give humans diseasesWebIonis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time IONS stock price. can chickens get tapeworms from eating fleascan chickens go blindWeb13 apr. 2024 · IONS.OQ - Stock Price & Latest News Reuters SPX 4,105.02+0.36% IXIC 12,087.96+0.76% DJI 33,485.29+0.01% STOXX 458.94+0.51% FTSE 7,741.56+1.03% … can chickens go outside nowWebCompany. Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on cardiovascular and neurology franchises. The Company’s products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients with spinal … can chickens go in your gardenWebHistorical daily share price chart and data for Ionis Pharmaceuticals since 2024 adjusted for splits. The latest closing stock price for Ionis Pharmaceuticals as of April 13, 2024 … can chickens get too cold